Advertisement
Paper| Volume 37, ISSUE 6, P651-658, March 15, 1985

The role of fibronectin in factor VIII/von Willebrand factor cryoprecipitation

DOI:https://doi.org/10.1016/0049-3848(85)90194-X
The role of fibronectin in factor VIII/von Willebrand factor cryoprecipitation
Previous ArticleWhole blood clot lysis: In vitro modulation by activated protein C
Next ArticleDestruction of ristocetin cofactor by coagulation at 4°C
      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      To evaluate the role of fibronectin (Fn) in factor VIII (FVIII) and von Willebrand factor (vWf) cryoprecipitation, factor VIII procoagulant activity, factor VIII coagulant antigen, factor VIII-related antigen and von Willebrand ristocetin cofactor activity were measured in cryoprecipitate and cryosupernatant from normal and Fn-depleted plasmas. Following cryoprecipitation of normal plasmas, most of the FVIII and almost all the FvWf recovered were found with a part of Fn and of fibrinogen in cryoprecipitate. Fn-depleted plasmas prepared either by affinity chromatography on gelatin or by immunoadsorption on monoclonal anti-Fn antibodies behaved differently : although their cryoprecipitate contained normal fibrinogen levels, neither FVIII nor FvWf was precipitated. Experiments performed with Fn-depleted plasma to which purified fibronectin had been added, and samples of plasma with decreased Fn levels (0.01 to 0.2 g/l) suggest that there is a relation between initial Fn level and the extent of FVIII/vWf cryoprecipitation. We conclude that Fn, like fibrinogen, is necessary to induce cryoprecipitation of FVIII/vWf and that an initial plasma level of 0.2 g/l is sufficient to obtain good recovery of FVIII/vWf in cryoprecipitate.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Thrombosis Research
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Pool J.G
        • Hershgold E.J
        • Pappenhagen A.R.
        High potency antihemophilic factor concentrate prepared from cryoglobulin precipitate.
        Nature. 1964; 203: 312-319
        • Polson A.
        • Ruiz-Bravo C.
        Fractionation of plasma with polyethylene glycol.
        Vox. Sang. 1972; 23: 107-118
        • Chang E.C.
        Segragation of proteins and sodium in human plasma upon freezing.
        Vox. Sang. 1983; 414: 238-245
        • Amrani D.L.
        • Mosesson M.W.
        • Hoyer L.W.
        Distribution of plasma fibronectin (CIG) and components of the factor VIII complex after heparin-induced precipitation of plasma.
        Blood. 1982; 59: 657-663
        • Reilly J.T.
        • Mc Verry B.A.
        • MacKie M.J.
        Fibronectin in blood products.
        in: An in vitro and in vivo study. J. Clin. Pathol.36. 1983: 1377-1381
        • Soulier J.P.
        • Larrieu M.J.
        Nouvelle méthode de diagnostic de l'hémophilie.
        in: Dosage des facteurs antihémophiliques A et B. Sang.24. 1953: 205-215
        • Girma J.P.
        • Lavergne J.M.
        • Meyer D.
        • Larrieu M.J.
        Immunoradiometric assay of factor VIII:coagulant antigen using four human antibodies.
        in: Study of 27 cases of haemophilia A. Brit. J. Haematol.47. 1981: 269-282
        • Mazurier C.
        • Parquet-Gernez A.
        • Goudemand M.
        Dosage de l'antigéne lié au facteur VIII par la technique ELISA.
        in: Interet dans l'étude de la maladie de Willebrand. Path. Biol.25. 1977: 18-24 (suppl.)
        • Mazurier C.
        • Parquet-Gernez A.
        • Samor B.
        • Goudemand M.
        • Montreuil J.
        Etude de l'antigéne lié au facteur VIII (FVIIIR:Ag).
        in: Purification par chromatographie d'immuno-affinité. C.R. Acad. Sc. Paris. 288. 1979: 1431-1434
        • Meyer D.
        • Jenkins C.S.
        • Dreyfus M.D.
        • Fressinaud E.
        • Larrieu M.J.
        Willebrand factor and ristocetin. II : Relationship between Willebrand factor, Willebrand antigen and factor VIII activity.
        Brit. J. Haematol. 1974; 28: 579-589
        • Nicholls D.G.
        • Hampton J.R.
        Density gradient separation of human platelets from plasma and the role of plasmas in adenosine diphosphate induced platelet electrophoretic mobility changes.
        Thromb. Diath. Haemorrh. 1972; 27: 425-433
        • Lefevre A.
        • Mazurier C.
        • Goudemand M.
        Etude comparative de trois techniques de dosage de la fibronectine plasmatique.
        in: Résultats chez le sujet normal. Rev. Fr. Transfus. Immunohématol.26. 1983: 135-145
        • Engvall E.
        • Ruoslahti E.
        Binding of soluble form of fibroblast surface protein, fibronectin, to collagen.
        Int. J. Cancer. 1977; 20: 1-5
        • Over J.
        • Bouma B.N.
        • Van Mourik J.A.
        • Sixma J.J.
        • Vlooswijk R.
        • Barker-Woudenberg I.
        Heterogeneity of human factor VIII. I : Characterization of factor VIII present in the supernatant of cryoprecipitate.
        J. Lab. Clin. Med. 1978; 91: 32-46
        • Over J.
        • Bouma B.N.
        • Sixma J.J.
        • Bolhuis P.A.
        Heterogeneity of human factor VIII. III : Transitions between forms of factor VIII present in cryoprecipitate and in cryosupernatant plasma.
        J. Lab. Clin. Med. 1980; 95: 323-334
        • Hellings J.A.
        • Over J.
        • Van Mourik J.A.
        The effects of storage of whole blood on the association of factor VIII-related antigen and factor VIII-coagulant antigen.
        Scand. J. Haematol. 1982; 29: 353-362
        • Gobbi F.
        The fractionation properties of human factor VIII (anti-hemophilic factor).
        Thromb. Diath. Haemorrh. 1960; 4: 253-260
        • Stathakis N.
        • Mosesson M.W.
        Interactions among heparin, cold insoluble globulin, and fibrinogen in formation of the heparin precipitable fraction of plasma.
        J. Clin. Invest. 1977; 60: 855-865
        • Seghatchian M.J.
        • MacKie I.J.
        • Mazurier C.
        • Goudemand M.
        The association of FVIII and fibronectin investigated by radiocrossed immunoelectrophoresis of FVIII clinical concentrates (abstract).
        in: Symposium on factor VIII/von Willebrand factor, San DiegoOctober 7–9 1982

      Article info

      Publication history

      Accepted: December 20, 1984
      Received: July 27, 1984

      Identification

      DOI: https://doi.org/10.1016/0049-3848(85)90194-X

      Copyright

      © 1985 Published by Elsevier Inc.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX